Patent · US Active

Compositions and methods for treating intestinal hyperpermeability

US10085959B2 · kind B2 · utility

7Cited by
14References
14Claims
0Family size

Inventor

Key dates

Filing dateSep 5, 2017
Grant dateOct 2, 2018
Priority date—
Expiry dateSep 5, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods, compositions, and kits for treating intestinal hyperpermeability in a subject in need thereof, including conditions such as hyperglycemia and underlying diseases such as diabetes, autism, fibromyalgia, inflammatory bowel disease (IBD), graft versus host disease (GVHD), HIV/AIDS, multiple organ dysfunction syndrome, irritable bowel syndrome (IBS), celiac disease, eczema, psoriasis, acute pancreatitis, Parkinson's disease, depression, chronic fatigue syndrome, asthma, multiple sclerosis, arthritis, ankylosing spondylitis, nonalcoholic fatty liver disease, alcoholic cirrhosis, environmental enteropathy, or kwashiorkor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.